St Louis Medical Clinic Pc

CLIA Laboratory Citation Details

3
Total Citations
14
Total Deficiencyies
5
Unique D-Tags
CMS Certification Number 26D0690592
Address 3009 N Ballas Rd, Suite 100b, Saint Louis, MO, 63131
City Saint Louis
State MO
Zip Code63131
Phone(314) 432-1111

Citation History (3 surveys)

Survey - October 30, 2018

Survey Type: Special

Survey Event ID: BCPE11

Deficiency Tags: D2016 D2096 D2016 D2096

Summary:

Summary Statement of Deficiencies D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on review of 2018 chemistry proficiency testing (PT) results reported to the CLIA database by the PT provider and phone interview with technical consultant the laboratory failed to successfully participate in PT. See D-tag 2096, unsatisfactory PT performance for the creatinine analyte for two out three consecutive testing events D2096 ROUTINE CHEMISTRY CFR(s): 493.841(f) Failure to achieve satisfactory performance for the same analyte or test in two Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- consecutive testing events or two out of three consecutive testing events is unsuccessful performance. This STANDARD is not met as evidenced by: Based on review of chemistry proficiency testing (PT) results for 2018 and phone interview with the technical consultant, the laboratory failed to achieve satisfactory performance for the creatinine analyte in two out of three consecutive PT events. Findings: 1. The laboratory obtained an unsatisfactory score of 40 percent for the creatinine analyte in the first PT event of 2018. 2. The laboratory obtained a satisfactory score of 100 percent for the creatinine analyte in the second PT event of 2018 based on laboratory evaluation of peer group data. 3. The laboratory obtained an unsatisfactory score of 60 percent for the creatinine analyte in the third PT event of 2018. 4. Phone interview with technical consultant on October 30, 2018 at 09:00 AM confirmed the laboratory failed to achieve satisfactory performance for the creatinine analyte. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - July 23, 2018

Survey Type: Special

Survey Event ID: RB0I11

Deficiency Tags: D2016 D2096 D2016 D2096

Summary:

Summary Statement of Deficiencies D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on review of 2018 chemistry proficiency testing (PT) results reported to the CLIA database by the PT provider and phone interview with testing personnel #1 the laboratory failed to successfully participate in PT. See D-tag 2096, unsatisfactory PT performance for the creatinine analyte for two consecutive testing events D2096 ROUTINE CHEMISTRY CFR(s): 493.841(f) Failure to achieve satisfactory performance for the same analyte or test in two Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- consecutive testing events or two out of three consecutive testing events is unsuccessful performance. This STANDARD is not met as evidenced by: Based on review of chemistry proficiency testing (PT) results for 2018 and phone interview with testing personnel #1, the laboratory failed to achieve satisfactory performance for the creatinine analyte in two consecutive PT events. Findings: 1. The laboratory obtained an unsatisfactory score of 40 percent for the creatinine analyte in the first PT event of 2018. 2. The laboratory obtained an unsatisfactory score of 40 percent for the creatinine analyte in the second PT event of 2018. 3. Phone interview with testing personnel #1 on July 23, 2018 at 2:00 PM confirmed the laboratory failed to achieve satisfactory performance for the creatinine analyte. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - May 9, 2018

Survey Type: Standard

Survey Event ID: PQE511

Deficiency Tags: D5403 D5439 D6019 D5403 D5439 D6019

Summary:

Summary Statement of Deficiencies D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) The procedure manual must include the following when applicable to the test procedure: (1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (2) Microscopic examination, including the detection of inadequately prepared slides. (3) Step-by-step performance of the procedure, including test calculations and interpretation of results. (4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (5) Calibration and calibration verification procedures. (6) The reportable range for test results for the test system as established or verified in 493.1253. (7) Control procedures. (8)

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access